HMGB1 immunostaining was unrelated to parameters of cancer aggressiveness in pancreatic and gastric adenocarcinomas, seminomas, as well as in endometrioid endometrial carcinomas. This evidence concerns the gene HMGB1 and endometrial endometrioid carcinoma.